BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8522481)

  • 1. Prognosis and staging of cutaneous T-cell lymphoma.
    Foss FM; Sausville EA
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1011-9. PubMed ID: 8522481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
    Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
    Starz H; Balda BR; Bachter D; Büchels H; Vogt H
    Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of cutaneous T-cell lymphoma.
    Burg G; Dummer R; Dommann S; Nestle F; Nickoloff B
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):961-95. PubMed ID: 8522491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection.
    Crane GA; Variakojis D; Rosen ST; Sands AM; Roenigk HH
    Arch Dermatol; 1991 Jul; 127(7):989-94. PubMed ID: 2064417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymphadenectomy for circumscribed cutaneous T-cell lymphoma.
    Wang CH; Nien HC; Hou MF; Chen GS; Cheng ST
    Dermatol Surg; 2004 Jun; 30(6):952-6. PubMed ID: 15171780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoma associated with the acquired immunodeficiency syndrome.
    Nahass GT; Kraffert CA; Penneys NS
    Arch Dermatol; 1991 Jul; 127(7):1020-2. PubMed ID: 2064400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond clonal detection: defining the T-cell clone.
    Guitart J
    Arch Dermatol; 2005 Sep; 141(9):1159-60. PubMed ID: 16172316
    [No Abstract]   [Full Text] [Related]  

  • 11. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged course of a cutaneous T-cell lymphoma with late systemic involvement.
    Ilan Y; Hillman M; Oren R; Kaufman B
    Br J Clin Pract; 1990 Dec; 44(12):731-3. PubMed ID: 2102216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 16. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
    Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
    J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analytical study of 13 cases of cutaneous lymphoma].
    Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
    Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.